Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.

Paraoxonase 2 (PON2) is a member of a gene family which also includes the more studied PON1, as well as PON3. PON2 is unique among the three PONs, as it is expressed in brain tissue. PON2 is a lactonase and displays anti-oxidant and anti-inflammatory properties. PON2 levels are highest in dopaminergic regions (e.g. striatum), are higher in astrocytes than in neurons, and are higher in brain and peripheral tissues of female mice than male mice. At the sub-cellular level, PON2 localizes primarily in mitochondria, where it scavenges superoxides. Lack of PON2 (as in PON2(-/-) mice), or lower levels of PON2 (as in male mice compared to females) increases susceptibility to oxidative stress-induced toxicity. Estradiol increases PON2 expression in vitro and in vivo, and provides neuroprotection against oxidative stress. Such neuroprotection is not present in CNS cells from PON2(-/-) mice. Similar results are also found with the polyphenol quercetin. PON2, given its cellular localization and antioxidant and anti-inflammatory actions, may represent a relevant enzyme involved in neuroprotection, and may represent a novel target for neuroprotective strategies. Its differential expression in males and females may explain gender differences in the incidence of various diseases, including neurodevelopmental, neurological, and neurodegenerative diseases.

[1]  A. Depino Peripheral and central inflammation in autism spectrum disorders , 2013, Molecular and Cellular Neuroscience.

[2]  L. Costa,et al.  Modulation of paraoxonase (PON1) activity. , 2005, Biochemical pharmacology.

[3]  M. Maraschin,et al.  Yerba mate (Ilex paraguariensis) enhances the gene modulation and activity of paraoxonase-2: in vitro and in vivo studies. , 2012, Nutrition.

[4]  H. Adami,et al.  Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.

[5]  M. Martinoli,et al.  Protective Effects of Resveratrol and Quercetin Against MPP+ -Induced Oxidative Stress Act by Modulating Markers of Apoptotic Death in Dopaminergic Neurons , 2009, Cellular and Molecular Neurobiology.

[6]  T. Hayek,et al.  Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice. , 2010, Atherosclerosis.

[7]  L. Goya,et al.  Quercetin Modulates NF-κ B and AP-1/JNK Pathways to Induce Cell Death in Human Hepatoma Cells , 2010, Nutrition and cancer.

[8]  S. Reddy,et al.  Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice. , 2006, Molecular genetics and metabolism.

[9]  A. S. Darvesh,et al.  Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity , 2010, Neuroscience.

[10]  Ying Sun,et al.  Female Adult Mouse Cardiomyocytes Are Protected Against Oxidative Stress , 2010, Hypertension.

[11]  J. Joven,et al.  Human tissue distribution of paraoxonases 1 and 2 mRNA , 2010, IUBMB life.

[12]  M. Marino,et al.  Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. , 2009, Molecular nutrition & food research.

[13]  T. Kavanagh,et al.  Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 expression. , 2013, Free radical biology & medicine.

[14]  S. Scherer,et al.  Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. , 1998, Gene.

[15]  Michael Aviram,et al.  Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta. , 2009, Cardiovascular research.

[16]  U. Förstermann,et al.  Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells , 2011, Cell Death and Disease.

[17]  R. Haley,et al.  Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-l-Homoserine Lactone , 2008, Infection and Immunity.

[18]  L. Garcia-Segura,et al.  Actions of estrogens on glial cells: Implications for neuroprotection. , 2010, Biochimica et biophysica acta.

[19]  M. Aviram,et al.  Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages. , 2004, Free radical biology & medicine.

[20]  G. Jarvik,et al.  Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. , 2003, Annual review of medicine.

[21]  Sang Hoon Kim,et al.  Transcriptional activation of an anti-oxidant mouse Pon2 gene by dexamethasone. , 2009, BMB reports.

[22]  B. La Du,et al.  Pharmacogenetics of paraoxonases: a brief review , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[23]  Lorene M Nelson,et al.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. , 2003, American journal of epidemiology.

[24]  P. McElduff,et al.  The paraoxonase‐2‐310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus , 2005, Journal of internal medicine.

[25]  E. Levy,et al.  Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[26]  S. Arnold,et al.  Estrogen and the regulation of mitochondrial structure and function in the brain , 2012, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  B. Ossola,et al.  The multiple faces of quercetin in neuroprotection , 2009, Expert opinion on drug safety.

[28]  S. Reddy,et al.  Impaired hepatic insulin signalling in PON2-deficient mice: a novel role for the PON2/apoE axis on the macrophage inflammatory response. , 2011, The Biochemical journal.

[29]  Aldons J Lusis,et al.  Paraoxonase-2 Deficiency Aggravates Atherosclerosis in Mice Despite Lower Apolipoprotein-B-containing Lipoproteins , 2006, Journal of Biological Chemistry.

[30]  V. A. Villar,et al.  Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. , 2012, Free radical biology & medicine.

[31]  R. Eliakim,et al.  Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. , 2005, Free radical biology & medicine.

[32]  B. La Du,et al.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. , 1996, Genomics.

[33]  S. Reddy,et al.  Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1 Published, JLR Papers in Press, December 16, 2008. , 2009, Journal of Lipid Research.

[34]  Jordi Oliver,et al.  Age and sex-related changes in rat brain mitochondrial oxidative status , 2011, Experimental Gerontology.

[35]  S. Reddy,et al.  Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. , 2009, Antioxidants & redox signaling.

[36]  Z. Madar,et al.  Glabridin, a phytoestrogen from licorice root, up‐regulates manganese superoxide dismutase, catalase and paraoxonase 2 under glucose stress , 2011, Phytotherapy research : PTR.

[37]  Xia Yang,et al.  A Common Mutation in Paraoxonase-2 Results in Impaired Lactonase Activity* , 2009, The Journal of Biological Chemistry.

[38]  B. Weiss Same sex, no sex, and unaware sex in neurotoxicology. , 2011, Neurotoxicology.

[39]  P. Beart,et al.  Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. , 2010, Journal of Alzheimer's disease : JAD.

[40]  A. Tward,et al.  Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. , 2000, Pharmacogenetics.

[41]  D. Shih,et al.  Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[42]  S. Reddy,et al.  Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein* , 2001, The Journal of Biological Chemistry.

[43]  M. Aviram,et al.  Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway , 2007, Biological chemistry.

[44]  C. Carlson,et al.  The Functional Consequences of Polymorphisms in the Human PON1 Gene , 2008 .

[45]  Y. Pi,et al.  Association between paraoxonase 2 Ser311Cys polymorphism and ischemic stroke risk: a meta-analysis involving 5,008 subjects , 2011, Molecular Biology Reports.

[46]  L. Costa,et al.  Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role? , 2011, Toxicology and applied pharmacology.

[47]  E. Levy,et al.  The three-gene paraoxonase family: physiologic roles, actions and regulation. , 2011, Atherosclerosis.

[48]  R. Kavlock,et al.  Implications of gender differences for human health risk assessment and toxicology. , 2007, Environmental research.

[49]  R. Gainetdinov,et al.  The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.

[50]  R. Sunahara,et al.  Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M , 2005, Journal of Lipid Research.

[51]  B. Liu,et al.  Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways , 2011, Psychoneuroendocrinology.

[52]  L. Costa,et al.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. , 2011, Biochemical pharmacology.

[53]  L. Costa,et al.  Modulation of Paraoxonase 2 (PON2) in Mouse Brain by the Polyphenol Quercetin: A Mechanism of Neuroprotection? , 2013, Neurochemical Research.

[54]  Manabu T. Nakamura,et al.  Increased macrophage cholesterol biosynthesis and decreased cellular paraoxonase 2 (PON2) expression in Delta6-desaturase knockout (6-DS KO) mice: beneficial effects of arachidonic acid. , 2010, Atherosclerosis.

[55]  C. Watson,et al.  Mouse Macrophage Paraoxonase 2 Activity Is Increased Whereas Cellular Paraoxonase 3 Activity Is Decreased Under Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[56]  T. Hong,et al.  Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease , 2012, Evidence-based complementary and alternative medicine : eCAM.

[57]  S. Klein,et al.  The effects of hormones on sex differences in infection: from genes to behavior , 2000, Neuroscience & Biobehavioral Reviews.

[58]  G. Rimbach,et al.  Effect of Quercetin on Paraoxonase 2 Levels in RAW264.7 Macrophages and in Human Monocytes––Role of Quercetin Metabolism , 2009, International journal of molecular sciences.

[59]  S. Arnold,et al.  Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons. , 2010, Biochimica et biophysica acta.

[60]  L. Garcia-Segura,et al.  Neuroprotective actions of estradiol revisited , 2011, Trends in Endocrinology & Metabolism.

[61]  M. Aschner,et al.  Gender and manganese exposure interactions on mouse striatal neuron morphology. , 2011, Neurotoxicology.

[62]  J. Simpkins,et al.  Mitochondrial mechanisms of estrogen neuroprotection. , 2010, Biochimica et biophysica acta.

[63]  U. Förstermann,et al.  Paraoxonases-2 and -3 Are Important Defense Enzymes against Pseudomonas aeruginosa Virulence Factors due to Their Anti-Oxidative and Anti-Inflammatory Properties , 2012, Journal of lipids.

[64]  D. Surmeier,et al.  The origins of oxidant stress in Parkinson's disease and therapeutic strategies. , 2011, Antioxidants & redox signaling.

[65]  C. Franceschi,et al.  Paraoxonase2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acute myocardial infarction in elderly patients. , 2009, Molecular genetics and metabolism.

[66]  T. Emanuelli,et al.  Protective properties of quercetin against DNA damage and oxidative stress induced by methylmercury in rats , 2011, Archives of Toxicology.

[67]  S. Reis,et al.  Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. , 2003, American journal of human genetics.

[68]  R. Haley,et al.  Paraoxonase 2 is down-regulated by the Pseudomonas aeruginosa quorumsensing signal N-(3-oxododecanoyl)-L-homoserine lactone and attenuates oxidative stress induced by pyocyanin. , 2010, The Biochemical journal.

[69]  U. Förstermann,et al.  Paraoxonase-2 Reduces Oxidative Stress in Vascular Cells and Decreases Endoplasmic Reticulum Stress–Induced Caspase Activation , 2007, Circulation.

[70]  B. Halliwell Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? , 2008, Archives of biochemistry and biophysics.

[71]  E. Levy,et al.  Comparative expression analysis reveals differences in the regulation of intestinal paraoxonase family members. , 2009, The international journal of biochemistry & cell biology.

[72]  A. Tward,et al.  Expression of human paraoxonase (PON1) during development. , 2003, Pharmacogenetics.

[73]  Corinna Wu,et al.  Of Mice and Women: The Bias in Animal Models , 2010 .

[74]  S. Arnold,et al.  Sex‐ and brain region‐specific role of cytochrome c oxidase in 1‐methyl‐4‐phenylpyridinium‐mediated astrocyte vulnerability , 2011, Journal of neuroscience research.

[75]  T. Hayek,et al.  Decreased Macrophage Paraoxonase 2 Expression in Patients With Hypercholesterolemia Is the Result of Their Increased Cellular Cholesterol Content: Effect of Atorvastatin Therapy , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[76]  Protective Role of Quercetin on PCBs-Induced Oxidative Stress and Apoptosis in Hippocampus of Adult Rats , 2012, Neurochemical Research.

[77]  M. Aviram,et al.  Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[78]  R. Niranjan The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes , 2013, Molecular Neurobiology.

[79]  The female advantage in cardiovascular disease: Do vascular beds contribute equally? , 2007 .

[80]  Sally Helgesen,et al.  The Female Advantage , 1990 .

[81]  M. Aviram,et al.  Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation. , 2007, Atherosclerosis.

[82]  U. Förstermann,et al.  One Enzyme, Two Functions , 2010, The Journal of Biological Chemistry.

[83]  J. Joven,et al.  Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. , 2008, Free radical biology & medicine.

[84]  A. Tamas,et al.  Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats , 2005, Behavioural Brain Research.

[85]  M. Hayashi Oxidative stress in developmental brain disorders , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[86]  C. Disteche,et al.  Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression. , 1997, Pharmacogenetics.

[87]  Malcolm K Horne,et al.  Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. , 2005, Biochemical pharmacology.

[88]  Yangbo Guo,et al.  Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese. , 2004, Brain research. Molecular brain research.

[89]  J. Joven,et al.  Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity. , 2009, Mini reviews in medicinal chemistry.